hotspot -WSS

hotspot

author：knowledge 2025-09-14 18:33:32 - browse：8

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Humana cuts profit projections as Medicare Advantage costs soar

hotspot

knowledge

WSS

New brain studies show LSD's effects on the brain in full color

AI generated plenty of interest at JPM but not a lot of trust

Readout Newsletter: Merck, J&J, and long Covid

Prior authorization will have to move faster under new Biden rule

Eli Lilly, Pfizer, and others want in on the online prescription market

Orangutan used medicinal plant to treat wound, first time ever seen

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Anesthesiologist group: stop taking Ozempic before surgery

New brain studies show LSD's effects on the brain in full color

Peter Hotez and the public health issue of online harassment

eGenesis tests gene

Affirmative action in medical school literally saved lives

Cholera vaccine supply gets boost as demand surges globally

hotspot

Medicare Advantage today, explained in one chart

Research misconduct: Proposed new rules face resistance

Eli Lilly, Pfizer, and others want in on the online prescription market

Element Biosciences CEO lays out genome sequencing strategy

AI generated plenty of interest at JPM but not a lot of trust

Test for long Covid? Researchers find new clue in blood samples

hotspot

hotspot

knowledge

entertainment